PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.23%
Some net income increase while MCHP is negative at -37.11%. John Neff would see a short-term edge over the struggling competitor.
5.51%
D&A growth well above MCHP's 0.18%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
61.18%
Lower deferred tax growth vs. MCHP's 451.61%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-25.00%
Both cut yoy SBC, with MCHP at -1.32%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-262.07%
Negative yoy working capital usage while MCHP is 145.48%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-277.50%
AR is negative yoy while MCHP is 227.74%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-726.09%
Negative yoy inventory while MCHP is 287.27%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-87.25%
Both negative yoy AP, with MCHP at -402.41%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
2910.00%
Growth well above MCHP's 22.52%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-1166.67%
Both negative yoy, with MCHP at -50.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
10.25%
Operating cash flow growth below 50% of MCHP's 38.48%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-23.68%
Negative yoy CapEx while MCHP is 20.03%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
12.06%
Purchases growth of 12.06% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-13.74%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-186.67%
Both yoy lines negative, with MCHP at -36.92%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
No Data
No Data available this quarter, please select a different quarter.
-993.33%
We cut debt repayment yoy while MCHP is 37.08%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-52.82%
Both yoy lines negative, with MCHP at -32.41%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-347.89%
We cut yoy buybacks while MCHP is 66.27%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.